• Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice
  • Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice
24/7 Health News
No Result
View All Result
Home Article

COVID: China is developing its own mRNA vaccine – and it’s showing early promise

February 15, 2022
in Article
COVID: China is developing its own mRNA vaccine – and it’s showing early promise

Gorodenkoff/Shutterstock

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may be set to change. China is now developing its own mRNA vaccine.

Both the Sinovac and Sinopharm vaccines use a traditional design, containing whole forms of the coronavirus that have been inactivated – a tried-and-tested way of making vaccines that work. However, while these vaccines were initially quite good at stopping people getting symptomatic COVID, this protection waned significantly over time. These vaccines also offer poor protection against infection with omicron. This has put pressure on China to develop more effective vaccines, as it is pursuing a strict containment policy with the virus.

The mRNA vaccines work in a different way. They deliver a snippet of the coronavirus’s genetic code into the body, housed inside a lipid droplet. Once this gets inside cells, the code gets read and the cells produce copies of a key part of the coronavirus, its spike protein. The immune system then sees these spike proteins and mounts a response to them, generating immunity against the full virus should it be encountered in the future.

The mRNA vaccines initially generated high levels of protection against getting COVID. And while the protection offered by two doses wanes over time and offers little protection against infection with omicron, the mRNA vaccines appear to offer the best protection against an omicron infection when used as boosters. They also continue to offer very impressive protection against severe disease. Early results suggest a third dose of Sinovac, in comparison, is unable to stop infection with the new variant (though these results are still in preprint, meaning they’re awaiting review by other scientists).

Enter ARCoV

The mRNA vaccine technology therefore looks like it will offer the best protection against COVID in the future – hence China’s development of such a vaccine. But it hasn’t just jumped on the bandwagon. Development of ARCoV, China’s candidate mRNA vaccine, commenced in March 2020. The technology used is very similar to that in the Pfizer and Moderna vaccines, using modified messenger RNA from the virus, housed in a lipid droplet, to stimulate immunity.

Illustration of the SARS-CoV-2, showing the spike proteins on its surface
Existing mRNA vaccines create whole copies of the virus’s spike proteins (red). ARCoV just makes a small part of the spike.
US CDC/Wikimedia Commons

But rather than getting the immune system to respond to the full spike protein of the virus like the Pfizer and Moderna vaccines do, ARCoV gets the body to make copies of the receptor binding domain (RBD), a key subpart of the virus’s spike protein that it uses to attach to and enter cells. This part of the virus seems to be especially recognisable by the immune system, which suggests that targeting it could have a particularly good protective effect.

Another potential advantage ARCoV has over the earlier mRNA vaccines is that it is stable at 2-8°C for at least a month, which would make transporting, storing and delivering the vaccine much easier.

How well does it work?

The results of an initial study of the vaccine in humans, where 120 volunteers were vaccinated with varying doses, were published in January 2022 in the Lancet. The vaccine was found to be safe, but there was a higher rate of fever after vaccination, especially at higher doses, than was seen in early studies of the other mRNA vaccines. However, these fevers were short lived.

The study also measured the levels of antibodies and T cells against the virus that the volunteers produced after being vaccinated. The best antibody and T-cell responses were seen in the intermediate-dose group, with higher doses leading to a lower response. It’s not 100% clear why this was the case, but this may be due to the body’s non-specific immune response (its general purpose defences that attack all sorts of foreign invaders) destroying the vaccine at higher doses before it could have its desired effect.

And even in those receiving the intermediate dose, the antibodies and T-cell responses recorded were also lower than those generated by the existing mRNA vaccines, which raises questions around how effective this vaccine will be. However, the results of a much larger ongoing study will be needed to properly assess this. That larger trial will involve over 28,000 participants across China, Mexico and Indonesia and will be using the intermediate dose that was shown to work best in this initial study.

Some interim results are to be expected in the coming months. There’s also another trial underway that’s studying giving ARCoV as a booster following the Sinovac or Sinopharm vaccines. The results of these studies – both in terms of whether there are any adverse events and how well ARCoV prevents infection, severe disease and death – will dictate the future of this vaccine and China’s future approach to COVID. Should it fail, will China seek to purchase the some of the proven Pfizer and Moderna mRNA vaccines instead? Time will tell.

The Conversation

Eoghan De Barra receives funding from Health Research Board of Ireland

ShareTweetSharePin
Next Post
After the FDA issued warnings about antidepressants, youth suicides rose and mental health care dropped

After the FDA issued warnings about antidepressants, youth suicides rose and mental health care dropped

Most Read

What causes stuttering? A speech pathology researcher explains the science and the misconceptions around this speech disorder

What causes stuttering? A speech pathology researcher explains the science and the misconceptions around this speech disorder

December 15, 2022
morning back pain

Morning Again Ache Trigger Is Not the Mattress

October 11, 2021

Why Circadian Rhythms Matter for Your Health

July 30, 2024
lower back pain relief exercises

5 decrease again ache aid workouts

October 11, 2021

4 steps to building a healthier relationship with your phone

January 28, 2025
3 years after legalization, we have shockingly little information about how it changed cannabis use and health harms

3 years after legalization, we have shockingly little information about how it changed cannabis use and health harms

October 15, 2021
Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

December 14, 2022
bleeding in gum

When The Bleeding in gum Is Severe ?

October 11, 2021
Good Night Sleep

6 Causes of Good Evening Sleep

October 11, 2021
Kick up your heels – ballroom dancing offers benefits to the aging brain and could help stave off dementia

Kick up your heels – ballroom dancing offers benefits to the aging brain and could help stave off dementia

January 3, 2023
Biden is getting prostate cancer treatment, but that’s not the best choice for all men − a cancer researcher describes how she helped her father decide

Biden is getting prostate cancer treatment, but that’s not the best choice for all men − a cancer researcher describes how she helped her father decide

May 20, 2025
Ten small changes you can make today to prevent weight gain

Ten small changes you can make today to prevent weight gain

October 12, 2021

COVID vaccines: how one can pace up rollout in poorer international locations

October 5, 2021

This Simple Hygiene Habit Could Cut Your Risk of Stroke, New Research Reveals

February 1, 2025

Multiple sclerosis: the link with earlier infection just got stronger – new study

October 12, 2021
Support and collaboration with health-care providers can help people make health decisions

Support and collaboration with health-care providers can help people make health decisions

December 16, 2021
Greece to make COVID vaccines mandatory for over-60s, but do vaccine mandates work?

Greece to make COVID vaccines mandatory for over-60s, but do vaccine mandates work?

December 1, 2021
Five ways to avoid pain and injury when starting a new exercise regime

Five ways to avoid pain and injury when starting a new exercise regime

December 30, 2022
woman covered with white blanket

Exploring the Impact of Sleep Patterns on Mental Health

August 4, 2024

Maximize Your Performance – Sync with Your Circadian Rhythms

August 9, 2024
Why are some people faster than others? 2 exercise scientists explain the secrets of running speed

Why are some people faster than others? 2 exercise scientists explain the secrets of running speed

April 29, 2024
Backlash to transgender health care isn’t new − but the faulty science used to justify it has changed to meet the times

Backlash to transgender health care isn’t new − but the faulty science used to justify it has changed to meet the times

January 30, 2024
News of war can impact your mental health — here’s how to cope

Binge-eating disorder is more common than many realise, yet it’s rarely discussed – here’s what you need to know

December 2, 2022
As viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe

As viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe

December 14, 2022
GPs don’t give useful weight-loss advice – new study

GPs don’t give useful weight-loss advice – new study

December 16, 2022
Nutrition advice is rife with misinformation − a medical education specialist explains how to tell valid health information from pseudoscience

Nutrition advice is rife with misinformation − a medical education specialist explains how to tell valid health information from pseudoscience

January 28, 2025
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

May 21, 2025
Four ways to avoid gaining weight over the festive period – but also why you shouldn’t fret about it too much

Four ways to avoid gaining weight over the festive period – but also why you shouldn’t fret about it too much

December 22, 2022
Nurses’ attitudes toward COVID-19 vaccination for their children are highly influenced by partisanship, a new study finds

Nurses’ attitudes toward COVID-19 vaccination for their children are highly influenced by partisanship, a new study finds

December 2, 2022
How hot is too hot for the human body? Our lab found heat + humidity gets dangerous faster than many people realize

How hot is too hot for the human body? Our lab found heat + humidity gets dangerous faster than many people realize

July 6, 2022
  • Home
  • Health & Wellness
  • Disclaimer

© 2020 DAILY HEALTH NEWS

  • Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice

© 2020 DAILY HEALTH NEWS